Biovaxys Technology Corp
OTC:BVAXF
Intrinsic Value
The intrinsic value of one BVAXF stock under the Base Case scenario is 0.0003 USD. Compared to the current market price of 0.0271 USD, Biovaxys Technology Corp is Overvalued by 99%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Biovaxys Technology Corp
Fundamental Analysis

Revenue & Expenses Breakdown
Biovaxys Technology Corp
Balance Sheet Decomposition
Biovaxys Technology Corp
Current Assets | 1.3m |
Cash & Short-Term Investments | 157.4k |
Receivables | 468.2k |
Other Current Assets | 655.7k |
Free Cash Flow Analysis
Biovaxys Technology Corp
CAD | |
Free Cash Flow | CAD |
Earnings Waterfall
Biovaxys Technology Corp
Revenue
|
0
CAD
|
Operating Expenses
|
-4.1m
CAD
|
Operating Income
|
-4.1m
CAD
|
Other Expenses
|
-1.4m
CAD
|
Net Income
|
-5.5m
CAD
|
BVAXF Profitability Score
Profitability Due Diligence
Biovaxys Technology Corp's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Biovaxys Technology Corp's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
BVAXF Solvency Score
Solvency Due Diligence
Biovaxys Technology Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Biovaxys Technology Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BVAXF Price Targets Summary
Biovaxys Technology Corp
Dividends
Current shareholder yield for BIOV is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one BVAXF stock under the Base Case scenario is 0.0003 USD.
Compared to the current market price of 0.0271 USD, Biovaxys Technology Corp is Overvalued by 99%.